替罗非班致血小板减少5例

Tirofiban-induced thrombocytopenia in 5 cases

  • 摘要: 目的 探讨替罗非班致血小板减少的诊断和处理策略。 方法 收集我院老年心血管病研究所2012年1月-2013年10月5例盐酸替罗非班致血小板减少症患者的病历资料,进行回顾性分析。 结果 5例患者入院时血小板均在正常范围,应用替罗非班的1 ~ 14 h发生血小板减少,其中4例为极重度血小板减少,1例为轻度血小板减少,最低血小板计数为6×109/L。及时发现并停用替罗非班及其他抗血小板、抗凝药物后,血小板计数于12 ~ 120 h时恢复正常范围,未发生颅内出血及消化道出血等致命性出血。 结论 用药后2 h、6 h以及24 h常规检测血小板,能够发现绝大多数替罗非班致血小板减少,出现血小板减少时及时停用并积极处理,能避免不良事件的发生。

     

    Abstract: Objective To study the diagnosis and treatment of tirofiban-induced thrombocytopenia. Methods Clinical data about 5 patients with tirofiban-induced thrombocytopenia admitted to Institute of Geriatric Cardiology in Chinese PLA General Hospital from January 2012 to October 2013 were retrospectively analyzed. Results The number of platelets was normal in the 5 patients at admission. Severe and mild thrombocytopenia occurred in 4 and 1 patients, respectively, after 1-14 h tirofiban treatment. The minimal number of platelets was 6×109/L. The number of platelets returned to normal 12-120 h after discomtinvation of tirofiban treatment. No fatal intracranial and gastrointestinal bleeding occurred. Conclusion Routine laboratory test of platelets can detect tirofibaninduced thrombocytopenia at 2, 6 and 24 h drug treatment. Drugs should be withdrawn immediately when thrombocytopenia occurs in order to avoid adverse events.

     

/

返回文章
返回